BioWorld MedTech

Aug. 11, 2011

Med-tech faces uncertainty in healthcare landscape

ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily) Read More

Washington roundup: CMS eyes wider indication for extracorporeal photopheresis

International report: First Latin American use of Medtronic Symplicity performed

New ventures: Misonix now enters surgical wound debridement market

Deals roundup: Despite buyout rejection, Alere acquires more Axis-Shield stock

Financings roundup: Masimo's board authorizes repurchase of up to 3M shares

Agreements/contracts: TrovaGene stops Sequenom, regains transrenal tech rights

Grants roundup: ApoCell awarded $2.9M contract for 12 alpha prototype units

HIT roundup: Boston Sci launches NLI for spinal cord stimulation

Med-Tech Notes

People in the News

Product Briefs

Abbott Vascular gets FDA approval for RX Herculink

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for April 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 11, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

FDA clears Dexcom G7 15 Day

BioWorld MedTech

The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...